Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.49 |
| ▸ | CA1 | P00915 | 5/20 | 0.49 |
| ▸ | CA9 | Q16790 | 4/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | MAX | P61244 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ATIC | P31939 | 1/20 | 0.40 |
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9669736 | 0.86 | MYC (0.50) | CDK2CA2CA1CA9LDHA | |
| SCHEMBL9670672 | 0.86 | TTR (0.47) | CDK2HSD17B10CYP1A2HPGDBLM | |
| SCHEMBL9670649 | 0.81 | HSD17B10 (0.48) | CDK2CA2CA1CA9LDHA | |
| SCHEMBL5886278 | 0.79 | ALDH1A1 (0.54) | CDK2CA2CA1CA9LDHA | |
| Nbqx SCHEMBL29412437 | 0.76 | MAPT (0.74) | CDK2CA2CA1CA9HSD17B10 | |
| Nbqx SCHEMBL220464 | 0.76 | MAPT (0.74) | CDK2CA2CA1CA9HSD17B10 | |
| SCHEMBL9670429 | 0.76 | TYMS (0.41) | CYP1A2MAPTKMT2AMYCMAX | |
| Nbqx SCHEMBL30728067 | 0.75 | MAPT (0.73) | CDK2CA2CA1CA9HSD17B10 | |
| Nbqx SCHEMBL26985644 | 0.75 | MAPT (0.73) | CDK2CA2CA1CA9HSD17B10 | |
| SCHEMBL9138970 | 0.74 | CDK2 (0.78) | CDK2CA2CA1CA9LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101879-B2 | Treatments for neurotoxicity in Alzheimer's Disease | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-09-05 | — | — | US | claimed |
| EP-1015013-A4 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES | MASSACHUSETTS INST TECHNOLOGY (US) | 2002-07-24 | — | — | EP | claimed |
| US-6172043-B1 | GENETIC ENGINEERED POLYPEPTIDE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-01-09 | — | — | US | claimed |
| EP-1015013-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-07-05 | — | — | EP | claimed |
| WO-1998030229-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY β-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-07-16 | — | — | WO | claimed |
| US-4889855-A | ADMINISTERING GLUTAMATE ANTAGONIST TO INHIBIT HYPERACTIVITY OF EXCITATORY NEUROTRANSMITTERS | A/S FERROSAN (DK) | 1989-12-26 | — | — | US | claimed |
| EP-1474126-A4 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-08-08 | — | — | EP | disclosed |
| US-7101879-B2 | Treatments for neurotoxicity in Alzheimer's Disease | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-09-05 | — | — | US | disclosed |
| US-7067550-B2 | Treatments for neurotoxicity in Alzheimer's Disease | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-06-27 | — | — | US | disclosed |
| EP-1341548-A4 | METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY $g(b)-AMYLOID PEPTIDES | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-06-14 | — | — | EP | disclosed |
| US-6942963-B1 | Methods for identifying treatments for neurotoxicity in Alzheimer's disease caused by β-amyloid peptides | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-09-13 | — | — | US | disclosed |
| EP-1474126-A2 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-11-10 | — | — | EP | disclosed |
| EP-1341548-A2 | METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY $g(b)-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2003-09-10 | — | — | EP | disclosed |
| US-6172043-B1 | GENETIC ENGINEERED POLYPEPTIDE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-01-09 | — | — | US | disclosed |
| EP-1015013-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1998030229-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY β-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-07-16 | — | — | WO | disclosed |
| EP-0283959-B1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1992-01-02 | — | — | EP | disclosed |
| US-4912108-A | Containing hydroxy substitution | A/S FERROSAN (DK) | 1990-03-27 | — | — | US | disclosed |
| US-4889855-A | ADMINISTERING GLUTAMATE ANTAGONIST TO INHIBIT HYPERACTIVITY OF EXCITATORY NEUROTRANSMITTERS | A/S FERROSAN (DK) | 1989-12-26 | — | — | US | disclosed |
| EP-0283959-A1 | Heterocyclic compounds and their preparation and use | NOVO NORDISK A/S (DK) | 1988-09-28 | — | — | EP | disclosed |